Atrial Fibrillation Market Strategies and Share 2031
The atrial fibrillation market is expected to grow from US$ 9,511.05 million in 2022 to US$ 20,925.79 million by 2031; it is expected to grow at a CAGR of 14.11% from 2022 to 2031.
The market's growth is attributed to the increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation. However, the high cost of atrial fibrillation devices and procedures is hampering the atrial fibrillation market growth.
Atrial fibrillation, AFib, or AF, is a medical condition that causes irregular heartbeats (arrhythmia) and can lead to blood clots, stroke, heart failure, and other heart-related complications. In this condition, the heart's upper chambers (known as atria) beat irregularly and thus cannot pump blood through its chambers. The medicines used to treat atrial fibrillation are blood thinners, heart rate, and heart rhythm medicines. If the medicines do not work, electrical cardioversion, cardiac ablation, and surgeries are preferred as the next treatment option.
Asia Pacific is the fastest-growing region in the global atrial fibrillation market. China, Japan, and India are among the key contributors to the market in this region. The driving factors in the region include increasing incidences of cardiovascular diseases, increasing geriatric population, growing awareness on better treatment procedures and advancement in technology are expected to equally influence the overall growth of market during the forecast period. Additionally, increasing availability of diagnostic and treatment services in countries such as India and large patient population contribute to the growth of the market.
Strategic Insights
Market Insights
Rising Awareness Regarding Atrial Fibrillation
Atrial fibrillation is among the most commonly occurring heart condition, which causes irregular and often abnormally fast heart rates, possibly leading to a stroke. A large number of populations across the globe are unaware of the symptoms associated with atrial fibrillation and hence remain untreated. For instance, according to the Centers for Diseases Control and Prevention estimates that by 2031, ~12.1 million people will have atrial fibrillation in the US. The data states that ~454,000 hospitalizations are observed yearly for atrial fibrillation in the US, leading to 158 000 deaths. It is said that millions of Americans are unaware of the atrial fibrillation condition. Therefore, Various associations worldwide have been involved in undertaking awareness regarding a medical conditions. For instance, Health Innovation Manchester in November 2021 raised awareness regarding Atrial Fibrillation and other innovative technologies to increase disease detection as part of Global AF Aware Week.
Other than bodies such as associations and organizations, companies in the market have also played an instrumental role in increasing awareness regarding atrial fibrillation. For instance, in February 2023, Bristol Myers Squibb and Pfizer, Inc. collaborated with Kareem Abdul-Jabbar, a basketball player, to raise awareness of atrial fibrillation and its symptoms through their campaign No Time to Wait Campaign. Similarly, in November 2021, Biosense Webster, a Division of Johnson & Johnson, launched two major initiatives for the Global AF Aware Week, which falls between 18–24 November. As a part of the Get Smart About AFIB (GSAAF) action, the company entered into a strategic partnership with the Arrhythmia Alliance to increase knowledge of AF across the healthcare community and the general public.
As awareness helps improve the medical care needed to treat atrial fibrillation, the market is expected to witness considerable growth during the forecast period.
Treatment Type-Based Insights
Based on treatment type, the atrial fibrillation market is segmented into non-pharmacological and pharmacological. The non-pharmacological segment held a larger market share in 2022 and is anticipated to register a higher CAGR during 2022–2031. The non-pharmacological segment is further divided into the surgical maze, catheter ablation, and electric cardioversion. In 2022, the MAZE surgery segment held the largest share of the market. However, the catheter ablation segment is estimated to register the highest CAGR in the market during the forecast period
End User-Based Insights
Based on end user, the atrial fibrillation market is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories. The hospitals segment accounted for the largest market share in 2021, and it is estimated to register the highest CAGR during the forecast period.
Companies operating in the atrial fibrillation market are adopting the inorganic and organic strategies to meet the evolving customer demands across the world, which further permits them to maintain their brand name in the global market.
- In August 2022, Medtronic completed acquisition of Affera, a Massachusetts-based healthcare technology company, dedicated to offer treatment of arrhythmias. Medtronic acquired Affera US$ 925 million and Medtronic had 3% of ownership in Affera well before this deal was announced.
- In May 2021, Royal Philips signed a collaboration deal with Medtronic plc. This collaboration will likely advance the treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder.
- In January 2021, Medtronic plc. acquired EPIX Therapeutics, Inc. This acquisition is likely to expand the Medtronic cardiac ablation portfolio to offer physicians a comprehensive set of tools to treat patients with cardiac arrhythmias.
- In August 2021, AtriCure, Inc. acquired SentreHEART, Inc. With this, the company will likely increase its product portfolio in the atrial ablation field.
Atrial Fibrillation Market: Competitive Landscape and Key Developments
Some key companies operating in the atrial fibrillation market include Boston Scientific Corporation; Medtronic; AtriCure, Inc; Johnson & Johnson (Biosense Webster, Inc.); BOEHRINGER INGELHEIM GMBH; CardioFocus; Abbott; Sanofi; Biotronik, Inc.; and Bristol-Myers Squibb Company. These players focus on expanding and diversifying their market presence and acquiring a novel customer base, thereby tapping prevailing business opportunities.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment Type, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Atrial fibrillation also referred to as AFib or AF is a medical condition that causes irregular heartbeat (arrhythmia) and which can further lead to blood clots, stroke, heart failure and other heart-related complications. In this condition, the upper chambers of the heart (known as atria) beat irregularly and thus cannot pump blood through its chambers.
Driving factors such as increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. Moreover, development opportunities in emerging countries is likely to have a positive impact on the growth of the market in the coming years.
The cost of the catheter ablation procedures and devices are higher in the North American region and developed nations. Atrial fibrillation (AF) ablation uses high cost technology and equipment. The average cost of catheter ablation ranges approximately from US $16,278 to US $21,294. However, it may differ in different regions.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Atrial Fibrillation Market – By Treatment Type
1.3.2 Global Atrial Fibrillation Market – By End User
1.3.3 Global Atrial Fibrillation Market – By Geography
2. Atrial Fibrillation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Atrial Fibrillation– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America – PEST Analysis
4.3 Expert Opinion
5. Atrial Fibrillation Market – Key Dynamics
5.1 Drivers
5.1.1 Increasing Prevalence Of Atrial Fibrillation
5.1.2 Rising Awareness Regarding Atrial Fibrillation
5.2 Restraints
5.2.1 High Cost Of Atrial Fibrillation Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in The Developing Nations
5.4 Future Trends
5.4.1 Development of Novel Technologies
5.5 Impact Analysis
6. Atrial Fibrillation Market – Global Analysis
6.1 Global Atrial Fibrillation Market Revenue Forecast And Analysis
6.2 Global Atrial Fibrillation Market, By Geography - Forecast And Analysis
6.3 Market Share of Key Players
6.3.1 Biosense Webster, Inc. (Johnson & Johnson)
6.3.2 Medtronic
7. Atrial Fibrillation Market Analysis and Forecast – By Treatment Type
7.1 Overview
7.2 Atrial Fibrillation Market, by Treatment Type, 2019 and 2027 (%)
7.3 Non-Pharmacological
7.3.1 Overview
7.3.2 Non-Pharmacological Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 MAZE Surgery
7.3.3.1 Overview
7.3.3.2 MAZE Surgery Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Catheter Ablation
7.3.4.1 Overview
7.3.4.2 Catheter Ablation Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Electric Cardioversion Market
7.3.5.1 Overview
7.3.5.2 Electric Cardioversion Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Pharmacological
7.4.1 Overview
7.4.2 Pharmacological Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Anti-Arrhythmic Drugs Market
7.4.3.1 Overview
7.4.3.2 Anti-Arrhythmic Drugs Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Anti-Coagulant Drugs Market
7.4.4.1 Overview
7.4.4.2 Anti-Coagulant Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8. Atrial Fibrillation Market Analysis and Forecast to 2027 – End-User
8.1 Overview
8.2 Atrial Fibrillation Market, by End-User, 2019 & 2027 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Ambulatory Surgical Centres
8.4.1 Overview
8.4.2 Ambulatory Surgery Centres Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Cardiac Catheterization Laboratories
8.5.1 Overview
8.5.2 Cardiac Catheterization Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
9. Atrial Fibrillation Market – Geographic Analysis
9.1 North America Atrial Fibrillation Market, Revenue and Forecast to 2027
9.1.1 Overview
9.1.2 North America Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.3 North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
9.1.3.1 North America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.3.2 North America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.4 North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.1.5 North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
9.1.6 United States
9.1.6.1 US Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.6.2 US Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.1.6.2.1 US Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.6.2.2 US Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.6.3 US Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.1.7 Canada
9.1.7.1 Canada Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.7.2 Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.1.7.2.1 Canada Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.7.2.2 Canada Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.7.3 Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.1.8 Mexico
9.1.8.1 Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.8.2 Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.1.8.2.1 Mexico Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.8.2.2 Mexico Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.8.3 Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027
9.2.1 Overview
9.2.2 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.3 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
9.2.3.1 Europe Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.3.2 Europe Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.4 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.5 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
9.2.6 Germany
9.2.6.1 Germany Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.6.2 Germany Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.2.6.2.1 Germany Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.6.2.2 Germany Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.6.3 Germany Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.7 United Kingdom
9.2.7.1 UK Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.7.2 UK Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.2.7.2.1 UK Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.7.2.2 UK Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.7.3 UK Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.8 France
9.2.8.1 France Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.8.2 France Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.2.8.2.1 France Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.8.2.2 France Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.8.3 France Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.9 Spain
9.2.9.1 Spain Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.9.2 Spain Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.2.9.2.1 Spain Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.9.2.2 Spain Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.9.3 Spain Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.10 Italy
9.2.10.1 Italy Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.10.2 Italy Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.2.10.2.1 Italy Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.10.2.2 Italy Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.2.10.3 Italy Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027
9.3.1 Overview
9.3.2 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.3 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
9.3.3.1 Asia Pacific Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.3.2 Asia Pacific Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.4 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.5 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
9.3.6 China
9.3.6.1 China Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.6.2 China Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.3.6.2.1 China Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.6.2.2 China Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.6.3 China Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.7 Japan
9.3.7.1 Japan Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.7.2 Japan Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.3.7.2.1 Japan Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.7.2.2 Japan Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.7.3 Japan Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.8 India
9.3.8.1 India Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.8.2 India Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.3.8.2.1 India Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.8.2.2 India Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.8.3 India Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.9 South Korea
9.3.9.1 South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.9.2 South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.3.9.2.1 South Korea Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.9.2.2 South Korea Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.9.3 South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.10 Australia
9.3.10.1 Australia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.10.2 Australia Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.3.10.2.1 Australia Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.10.2.2 Australia Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.3.10.3 Australia Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027
9.4.1 Overview
9.4.2 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.3 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
9.4.3.1 Middle East & Africa Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.3.2 Middle East & Africa Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.4 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.5 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
9.4.6 Saudi Arabia
9.4.6.1 Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.6.2 Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.4.6.2.1 Saudi Arabia Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.6.2.2 Saudi Arabia Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.6.3 Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.7 UAE
9.4.7.1 UAE Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.7.2 UAE Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.4.7.2.1 UAE Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.7.2.2 UAE Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.7.3 UAE Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.8 South Africa
9.4.8.1 South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.8.2 South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.4.8.2.1 South Africa Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.8.2.2 South Africa Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.4.8.3 South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027
9.5.1 Overview
9.5.2 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.3 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.5.3.1 South and Central America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.5.3.2 South and Central America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.5.4 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5.5 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
9.5.6 Brazil
9.5.6.1 Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.6.2 Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.5.6.2.1 Brazil Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.5.6.2.2 Brazil Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.5.6.3 Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5.7 Argentina
9.5.7.1 Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.7.2 Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
9.5.7.2.1 Argentina Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.5.7.2.2 Argentina Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.5.7.3 Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
10. Atrial Fibrillation Market –Industry Landscape
10.1 Overview
10.1.1 Recent Developments by Players in Atrial Fibrillation Market
11. Atrial Fibrillation Market- Key Company Profiles
11.1 Boston Scientific Corporation
11.1.1 1.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Medtronic
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 AtriCure, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Biosense Webster, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BOEHRINGER INGELHEIM GMBH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 CardioFocus.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Abbott
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Sanofi
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Bristol-Myers Squibb Company
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Biotronik, Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Prevalence of Atrial Fibrillation In APAC Region (By Country)
Table 2. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
Table 3. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 4. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 5. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 6. US Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 7. US Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 8. US Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 9. US Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 10. Canada Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 11. Canada Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 12. Canada Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 13. Canada Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 14. Mexico Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 15. Mexico Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 16. Mexico Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 17. Mexico Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 18. Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
Table 19. Europe Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 20. Europe Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 21. Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 22. Germany Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 23. Germany Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 24. Germany Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 25. Germany Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 26. UK Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 27. UK Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 28. UK Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 29. UK Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 30. France Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 31. France Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 32. France Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 33. France Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 34. Spain Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 35. Spain Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 36. Spain Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 37. Spain Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 38. Italy Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 39. Italy Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 40. Italy Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 41. Italy Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 42. Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
Table 43. Asia Pacific Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 44. Asia Pacific Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 45. Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 46. China Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 47. China Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 48. China Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 49. China Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 50. Japan Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 51. Japan Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 52. Japan Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 53. Japan Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 54. India Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 55. India Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 56. India Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 57. India Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 58. South Korea Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 59. South Korea Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 60. South Korea Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 61. South Korea Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 62. Australia Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 63. Australia Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 64. Australia Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 65. Australia Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 66. Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
Table 67. Middle East & Africa Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 68. Middle East & Africa Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 69. Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 70. Saudi Arabia Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 71. Saudi Arabia Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 72. Saudi Arabia Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 73. Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 74. UAE Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 75. UAE Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 76. UAE Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 77. UAE Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 78. South Africa Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 79. South Africa Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 80. South Africa Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 81. South Africa Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 82. South and Central America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 83. South and Central America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
Table 84. South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 85. Brazil Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 86. Brazil Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 87. Brazil Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 88. Brazil Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 89. Argentina Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
Table 90. Argentina Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 91. Argentina Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
Table 92. Argentina Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
Table 93. Recent Developments in THE atrial fibrillation market
Table 94. Glossary of Terms, Atrial Fibrillation Market
LIST OF FIGURES
Figure 1. Atrial Fibrillation Market Segmentation
Figure 2. Atrial Fibrillation Market Segmentation, By Region
Figure 3. Global Atrial Fibrillation Market Overview
Figure 4. Non-Pharmacological Segment Held Largest Share Of Treatment Type Segment In Atrial Fibrillation Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Atrial Fibrillation Market, By Geography (US$ Mn)
Figure 7. Global Atrial Fibrillation Market- Leading Country Markets (US$ Mn)
Figure 8. Global Atrial Fibrillation Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Atrial Fibrillation Market Impact Analysis of Drivers and Restraints
Figure 15. Global Atrial Fibrillation Market – Revenue Forecast And Analysis – 2018- 2027
Figure 16. Global Atrial Fibrillation Market – By Geography Forecast And Analysis – 2019- 2027
Figure 17. Market Share Of Key Player In Global Atrial Fibrillation Market
Figure 18. Atrial Fibrillation Market, by Treatment Type, 2019 and 2027 (%)
Figure 19. Non-Pharmacological Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. MAZE Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Catheter Ablation Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Electric Cardioversion Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Pharmacological Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Anti-Arrhythmic Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Anti-Coagulant Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Atrial Fibrillation Market, by End-User, 2019 & 2027 (%)
Figure 27. Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Ambulatory Surgery Centres Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Cardiac Catheterization Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
Figure 31. North America Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
Figure 32. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
Figure 33. US Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 34. Canada Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 35. Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 36. Europe Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
Figure 37. Europe Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
Figure 38. Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
Figure 39. Germany Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 40. UK Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 41. France Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 42. Spain Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 43. Italy Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 44. Asia Pacific Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
Figure 45. Asia Pacific Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
Figure 46. Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
Figure 47. China Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 48. Japan Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 49. India Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 50. South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 51. Australia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 52. Middle East & Africa Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
Figure 53. Middle East & Africa Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
Figure 54. Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
Figure 55. Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 56. UAE Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 57. South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 58. South and Central America Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
Figure 59. South and Central America Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
Figure 60. South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
Figure 61. Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 62. Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
The List of Companies - Atrial Fibrillation Market
- Boston Scientific Corporation
- Medtronic
- AtriCure, Inc
- Biosense Webster, Inc.
- BOEHRINGER INGELHEIM GMBH
- CardioFocus
- Abbott
- Sanofi
- Biotronik Inc.
- Bristol-Myers Squibb Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For